FN1 and pulmonary fibrosis: ,46,66 The primary phenotypic screening assay endpoint for hit selection includes multiparametric analysis of the deposition of multiple ECM proteins associated with clinical lung fibrosis, including collagens I, III, and IV and fibronectin.